The US Patent and Trademark Office (USPTO) has granted a patent to Genprex for the use of its Reqorsa gene therapy in ...

Science and Technology Minister, Dr. Jitendra Singh today launched country’s first indigenous CRISPR based gene therapy for ...

India launched its first indigenous CRISPR-based gene therapy, 'BIRSA 101,' to combat sickle cell disease, prevalent among ...

Hyderabad: BRIC-Translational Health Science and Technology Institute (BRIC-THSTI), in collaboration with Miltenyi Biotec and ...

The breakthrough marks the country’s entry into advanced gene-editing therapeutics, an area so far dominated by a handful of global companies.

“With the development and transfer of India’s first indigenous CRISPR-based gene therapy, the nation has taken a major step toward fulfilling Prime Minister Narendra Modi’s vision of a Sickle ...

Strengthens Intellectual Property Portfolio and Provides Protection for Therapeutic Combination in Acclaim-3 Clinical Trial ...

CRISPR gene-editing technology lets scientists make precise changes to an organism’s DNA. Invented in 2012 by Jennifer Doudna ...

Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its ...

Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS ...

A recent review published in Genes & Diseases by researchers from the Naval Medical University and the 922nd Hospital of the Joint Service Support Force of the PLA provides a comprehensive overview of ...

In this week’s Focus on Health, Dr. Robin Miller shares encouraging research showing that a new gene therapy slowed disease ...